Related Experiment Videos
Post-irradiation leiomyosarcoma. Case report with immunohistochemical studies.
Journal of Submicroscopic Cytology
|April 1, 1987
Summary
This case study details a rare post-irradiation leiomyosarcoma, a muscle tumor, diagnosed 13 years after radiation therapy for a misdiagnosed breast carcinoma. This highlights a potential long-term risk following radiation exposure.
Area of Science:
- Oncology
- Pathology
- Radiology
Background:
- Leiomyosarcomas are rare malignant tumors arising from smooth muscle tissue.
- Post-irradiation sarcomas are a known but infrequent complication of radiation therapy.
- This report focuses on a specific instance of leiomyosarcoma developing after therapeutic irradiation.
Observation:
- A patient developed leiomyosarcoma 13 years after receiving 6,000 rads of radiation.
- The initial radiation was administered at age 13 due to a misdiagnosis of breast carcinoma.
- Immunohistochemical analysis confirmed the tumor's smooth muscle origin, showing positivity for vimentin and desmin.
Findings:
- Tumor cells were positive for vimentin and desmin, indicating smooth muscle differentiation.
- Absence of staining with anti-prekeratin and anti-epithelial membrane antigen ruled out epithelial origin.
- Negative staining with alpha-smooth muscle actin and alpha-striated muscle actin antibodies was noted, despite desmin positivity.
Implications:
- This case adds to the limited literature on post-irradiation leiomyosarcomas.
- It underscores the importance of long-term surveillance for patients who have undergone therapeutic radiation.
- Understanding the specific immunohistochemical profile can aid in diagnosing rare radiation-induced malignancies.